Peers of Cytodyn Inc (CYDY)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
1442.53x
As of Nov 29, 2022
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Nov 29, 2022 | 1442.53x |
| Nov 28, 2022 | 1413.65x |
| Nov 25, 2022 | 1435.31x |
| Nov 23, 2022 | 1442.53x |
| Nov 22, 2022 | 1431.34x |
| Nov 21, 2022 | 1478.63x |
| Nov 18, 2022 | 1518.34x |
| Nov 17, 2022 | 1502.82x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison